Cardiac Electrophysiology and Device Therapy bring together sophisticated mapping, ablation, and implantable technology to diagnose and treat complex rhythm disorders. This session provides a broad, clinically grounded overview of how electrophysiology (EP) studies, catheter ablation, pacemakers, ICDs, and cardiac resynchronization therapy can be combined to improve survival, reduce symptoms, and prevent sudden cardiac death. Participants will explore the full EP care continuum—from initial evaluation of palpitations and syncope through invasive procedures and long-term device follow-up.

Many clinicians and trainees search for a comprehensive cardiology conference that links core EP concepts with real-world decision-making. This session revisits mechanisms of supraventricular and ventricular arrhythmias, the role of invasive EP studies in defining substrates, and indications for ablation of atrial fibrillation, flutter, AVNRT, accessory pathways, and ventricular tachycardia. Attendees will learn how to weigh device therapy options for bradyarrhythmias, heart failure with dyssynchrony, and primary or secondary prevention of sudden death. Case discussions will highlight how to choose between catheter ablation, device implantation, or combined approaches, depending on patient profile and arrhythmia burden.

A major emphasis is on organizing device-based arrhythmia therapy as part of integrated rhythm management. Participants will examine programming strategies for pacemakers and ICDs, including detection zones, anti-tachycardia pacing, and shock settings tailored to individual risk. The session addresses CRT optimization, including AV and VV timing, and the management of nonresponders. Practical topics such as shared decision-making, end-of-life device management, and communication around ICD shocks are also covered.

Finally, the session explores emerging technologies in EP and device therapy—high-density mapping, pulsed field ablation, conduction system pacing, leadless devices, and subcutaneous ICDs. Attendees will consider training requirements, procedural volume thresholds, and quality metrics for EP labs. By the end, participants will have a cohesive framework for evaluating arrhythmia patients, selecting appropriate electrophysiologic and device-based therapies, and coordinating long-term follow-up.